The advent of genome-wide association studies (GWAS) in 2007 allowed the discovery of a large number of non-HLA markers for ACPA+ RA; large international consortia and meta-analysis permitted a massive increase in sample size and power in Caucasian and Asian populations [50, 51]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.